Stock data

達亞 (6762)

達亞 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$68.33M, up 26.5% from a year earlier. EPS over the last four quarters totals NT$0.49.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 達亞 in Insightr